IDSI pursues NASDAQ listing
Breast imaging developer Imaging Diagnostic Systems of Plantation, FL, is trying to get listed on the NASDAQ stock exchange, but it has run into difficulty due to the stock exchange's listing requirements. One of NASDAQ's requirements is that IDSI
Breast imaging developer Imaging Diagnostic Systems of Plantation, FL, is trying to get listed on the NASDAQ stock exchange, but it has run into difficulty due to the stock exchange's listing requirements. One of NASDAQ's requirements is that IDSI execute a reverse stock split to bring the company's share prices above $4; however, IDSI's board determined that a reverse split would be detrimental to shareholders. IDSI reported that it would appeal the NASDAQ's requirements and continue to seek the listing.
In other IDSI news, the company announced that it has signed an agreement with Imation that enables IDSI to sell Imation's DryView laser printers with its CT Laser Mammography system, when CTLM becomes commercially available. IDSI will also begin to market DryView in the U.S. directly and internationally through its distributors. IDSI added a distributor in Turkey with the signing of an agreement with Emtron, which will have rights to market CTLM in the country for 18 months.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.
